State Street Corp Kura Oncology, Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Kura Oncology, Inc. stock. As of the latest transaction made, State Street Corp holds 2,884,541 shares of KURA stock, worth $56.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,884,541

Previous 4,199,954 31.32%

Holding current value

$56.3 Million

Previous $89.6 Million 33.7%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $23.1 Million - $30.2 Million	-1,315,413 Reduced 31.32%	2,884,541 $59.4 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $17.2 Million - $30.1 Million	1,278,144 Added 43.74%	4,199,954 $89.6 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $2.54 Million - $4.81 Million	-334,777 Reduced 10.28%	2,921,810 $42 Million
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $2.05 Million - $2.89 Million	243,439 Added 8.08%	3,256,587 $29.7 Million
Q2 2023 Aug 14, 2023	SELL	$9.62 - $13.99 $7.98 Million - $11.6 Million	-829,530 Reduced 21.59%	3,013,148 $31.9 Million
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $6.47 Million - $8.81 Million	-603,749 Reduced 13.58%	3,842,678 $47 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $872,166 - $1.31 Million	77,664 Added 1.78%	4,446,427 $55.2 Million
Q3 2022 Nov 15, 2022	BUY	$12.01 - $19.45 $16.1 Million - $26 Million	1,337,149 Added 44.11%	4,368,763 $59.7 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $2.88 Million - $4.93 Million	-269,134 Reduced 8.15%	3,031,614 $55.6 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $911,713 - $1.31 Million	-77,395 Reduced 2.29%	3,300,748 $53.1 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $2.07 Million - $3.31 Million	169,034 Added 5.27%	3,378,143 $47.3 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $702,118 - $988,976	-45,533 Reduced 1.4%	3,209,109 $60.1 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $8.78 Million - $12.6 Million	420,992 Added 14.86%	3,254,642 $67.9 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $3.87 Million - $6.12 Million	156,430 Added 5.84%	2,833,650 $80.1 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $27.4 Million - $39.4 Million	946,021 Added 54.65%	2,677,220 $87.4 Million
Q3 2020 Nov 10, 2020	BUY	$16.3 - $30.64 $1.26 Million - $2.37 Million	77,498 Added 4.69%	1,731,199 $53 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $4.53 Million - $10.7 Million	569,974 Added 52.59%	1,653,701 $27 Million
Q1 2020 May 11, 2020	BUY	$6.45 - $14.04 $6.99 Million - $15.2 Million	1,083,727 New	1,083,727 $10.8 Million

Others Institutions Holding KURA

# of Institutions

181

Shares Held

80.2M

Call Options Held

148K

Put Options Held

63K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.31B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Kura Oncology, Inc. Transaction History